Introduction

ETM

Experimental and Therapeutic Medicine

1792-0981 1792-1015

D.A. Spandidos

ETM-0-0-09869

10.3892/etm.2021.9869

Articles

Kuwanon G protects HT22 cells from advanced glycation end product-induced damage

Gan

Wen-Jun

1 * Gao

Chen-Lin

1 2 * Zhang

Wen-Qian

1 Gu

Jun-Ling

1 Zhao

Ting-Ting

1 Guo

Heng-Li

1 Zhou

Hua

1 Xu

Yong

2 Yu

Li-Li

1 Li

Li-Fang

1 Gui

Ding-Kun

3 Xu

You-Hua

1Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao SAR 999078, P.R. China 2Department of Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 510500, P.R. China 3Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China

Correspondence to: Dr Ding-Kun Gui, Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Haigang Avenue 500, Pudong New Area, Shanghai 200233, P.R. China dingkungui@alu.fudan.edu.cn

Dr You-Hua Xu, Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macao SAR 999078, P.R. China yhxu@must.edu.mo

^*Contributed equally

05 2021

25 02 2021

21 5

425

31 01 2019 11 09 2020

2020

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

The incidence of diabetic encephalopathy is increasing as the population ages. Evidence suggests that formation and accumulation of advanced glycation end products (AGEs) plays a pivotal role in disease progression, but limited research has been carried out in this area. A previous study demonstrated that Kuwanon G (KWG) had significant anti-oxidative stress and anti-inflammatory properties. As AGEs are oxidative products and inflammation is involved in their generation it is hypothesized that KWG may have effects against AGE-induced neuronal damage. In the present study, mouse hippocampal neuronal cell line HT22 was used. KWG was shown to significantly inhibit AGE-induced cell apoptosis in comparison with a control treatment, as determined by both MTT and flow cytometry. Compared with the AGEs group, expression of pro-apoptotic protein Bax was reduced and expression of anti-apoptotic protein Bcl-2 was increased in the AGEs + KWG group. Both intracellular and extracellular levels of acetylcholine and choline acetyltransferase were significantly elevated after KWG administration in comparison with controls whilethe level of acetylcholinesterase decreased. These changes in protein expression were accompanied by increased levels of superoxide dismutase and glutathione peroxidase synthesis and reduced production of malondialdehyde and reactive oxygen species. Intracellular signaling pathway protein levels were determined by western blot and immunocytochemistry. KWG administration was found to prevent AGE-induced changes to the phosphorylation levels of Akt, IκB-α, glycogen synthase kinase 3 (GSK3)-α and β, p38 MAPK and NF-κB p65 suggesting a potential neuroprotective effect of KWG against AGE-induced damage was via the PI3K/Akt/GSK3αβ signaling pathway. The findings of the present study suggest that KWG may be a potential treatment for diabetic encephalopathy.

acetylcholine advanced glycation end products diabetes encephalopathy Kuwanon G

Funding: The present study was supported by the Science and Technology Development Fund of Macau (grant. no. FDCT: 0093/2018/A3).

Introduction

Diabetic encephalopathy is one of the major chronic complications of diabetes mellitus (DM) (1). Symptoms of diabetic encephalopathy include slow reaction times, cognitive and memory dysfunction, severe cerebral thrombosis, stroke and Alzheimer's disease. Although the pathogenesis of diabetic encephalopathy is not fully understood, recent evidence suggestes that the formation and accumulation of advanced glycation end products (AGEs) plays a pivotal role. Acetylcholine (ACh) is important for the maintenance of central nervous system function (2). A study found that a reduced level of ACh may contribute to impaired learning and memory in diabetic rats (3).

Oxidative stress has a close relationship with the development of DM and diabetic encephalopathy (4). It has been demonstrated that ROS are a class of highly reactive free radical molecules that can directly damage cell viability and function (5), and that malondialdehyde (MDA) is one of the most important products of membrane lipid peroxidation and that its production can aggravate membrane damage (6). Superoxide dismutase (SOD) is an important antioxidant enzyme in organisms that can scavenge free radical molecules and glutathione peroxidase (GPX) is a peroxide-degrading enzyme widely distributed in organisms that can catalyze the reduction of toxic peroxides into non-toxic hydroxy compounds thus protecting the structure and function of cell membranes against peroxide damage (7,8). To comprehensively evaluate effects of KWG against oxidative stress, the above parameters were determined. It has also been demonstrated that high concentrations of flavonoids are cytotoxic (9). On the other hand, cell death is closely related with production of ROS (10). Cortex Mori [CM; Cortex Mori is the dry root bark of Morus alba (Latin scientific name, Morus alba L.)] is a traditional Chinese medicine believed to be beneficial in the treatment of DM. A previous study found that CM extract had an antidepressant-like effect on the rat hippocampus (11). Flavonoids have been widely reported to increase cell viability (12,13) and they are the main components of CM (14). Several studies have demonstrated the antiinflammatory, antioxidant and hypoglycemic effects of flavonoids from CM (15-17), but the specific molecule behind these effects is unknown. In a previous study, Kuwanon G (KWG), a flavonoid derived from CM, was suggested to have a beneficial effect against lipopolysaccharide-induced inflammation and oxidative stress (12). The antiinflammatory effect of KWG has been demonstrated by a number of research groups (9,18,19).

The HT22 cell line is a mouse hippocampal neuron cell line. This cell line is a good model for studying the toxicity of glutamate in vitro, and has good applications in many neurodegenerative diseases, such as Alzheimer's and Parkinson's disease (20,21). Therefore, HT22 cells were selected for the present study.

In the present study, the neuroprotective effects of KWG were explored in an in vitro model of a high glucose environment and the potential mechanisms underlying its action were investigated.

Materials and methods <sec> <title>Materials

Kuwanon G (Fig. 1A) was supplied by Chengdu Pufeide Biotech Co., Ltd. AGEs were prepared by incubating bovine serum albumin (BSA; Gibco; Thermo Fisher Scientific, Inc.) with 50 mM D-glucose (GBCBIO Technologies, Inc.) under sterile conditions in 5% CO₂/95% air at 37˚C for 3 months. Unincorporated glucose was then removed by dialysis overnight against 0.01 M phosphate-buffered saline (PBS). Unmodified BSA was incubated in the absence of glucose under the same conditions, to be used as a control. AGEs were stored at 4˚C until use (22-24). Primary antibodies against Akt (cat. no. sc-514032), phosphorylated (p)-Akt (cat. no. sc-8312), IκB-α (cat. no. sc-1643), p-IκB-α (cat. no. sc-8404), glycogen synthase kinase 3 (GSK3) α/β (cat. no. sc-7291), p-GSK3α/β (cat. no. sc-81496), GAPDH (cat. no. sc-47724) and RIPA Lysis Buffer (cat. no. sc-24948) were supplied by Santa Cruz Biotechnology, Inc. Antibodies for p38 MAPK (cat. no. 8690S), p-p38 MAPK (cat. no. 9216S), NF-κB p65 (cat. no. 8242S) and p-NF-κB p65 (cat. no. 3033S) were from Cell Signaling Technology, Inc. Bcl-2 (cat.no. bs-0032R) and Bax (cat. no. bs-0127R) primary antibodies, FITC- (cat. no. bs-0295D-FITC), Cy3- (cat. no. bs-0296G-Cy3), goat anti-rabbit IgG/FITC (cat. no. bs-0295G-FITC) and goat anti-mouse IgG/FITC (cat. no. bs-0296G-FITC) conjugated secondary antibodies were bought from BIOSS. The ELISA kit for ACh (cat. no. KTE70539) was purchased from Abbkine Scientific Co,. Ltd. DAPI (cat. no. C1002) was supplied by GBCBIO Technologies, Inc. An Annexin V-propidium iodide (AV-PI) kit (cat. no. KGA101) was purchased from Nanjing KeyGen Biotech Co., Ltd. Glutathione peroxidase (GPX; cat. no. S0056) and intracellular reactive oxygen species (ROS; cat. no. S0033S) detection kits were supplied by Beyotime Institute of Biotechnology. Superoxidase dismutase (SOD; cat. no. A001-3-2) and choline acetyltransferase (ChAT) kits (cat. no. A079-1-1) were supplied by Nanjing Jiancheng Bioengineering Institute. Kits for malondialdehyde (MDA; cat. no. BC0025) and acetylcholinesterase (AChE; cat. no. BC2025) were purchased from Beijing Solarbio Science & Technology Co., Ltd. Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), rabbit serum, penicillin-streptomycin Solution and trypsin were obtained from Gibco (Thermo Fisher Scientific, Inc.). Precision Plus Protein™ Dual Color Standards (cat. no. 161-0374) was supplied by Bio-Rad Laboratories, Inc.

Cell Culture

The HT22 cell line was a gift from Professor Lu Ming (Nanjing Medical University, China). Cells were cultured in DMEM supplemented with 10% heat-inactivated FBS at 37˚C in a humidified atmosphere of 5% CO₂ /95% air.

Cell viability evaluation by MTT assay

HT22 cells at an exponential growth phase were seeded on flat-bottomed 96-well plates, seeding density was 4x10⁴ cells/ml. Cells were treated with PBS (vehicle), AGEs, KWG or AGEs + KWG (the cells were incubated with AGEs for 30 min followed by KWG administration), as indicated for 24-48 h. Cells were then incubated with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (5 mg/ml) for 4 h in the cell culture incubator. Formazan was dissolved with dimethyl sulfoxide. Absorbance values at a wavelength of 490 nm were measured using a spectrophotometer (Tecan Group Ltd.).

AV-FITC/PI cell apoptosis detection assay

AV-PI assay was carried out to determine cell apoptosis levels. After treatment, the cells were washed twice with cold PBS, dissociated with EDTA-free trypsin (cat. no. PYG0107; Boster Biologicals) and 1x10⁶ cells/ml were harvested. A 5 µl volume of AV-FITC and 10 µl of PI were added sequentially. Cells were incubated in the dark at room temperature for 15 min with the stains before 400 µl of binding buffer was added to the sample and the apoptosis rate measured by flow cytometry. The Q2 and Q3 quadrants were counted to determine the level of apoptosis. For this aim, BD Aria III Flow Cytometer (BD Biosciences) and the FlowJo software (7.6; FlowJo LLC) were applied for determination and analysis.

Cell anti-oxidant activity assessment

HT22 cells were seeded in 24-well plates, seeding density was 1x10⁵ cells/ml and vehicle, Rosup (used as the positive control; Beyotime Institute of Biotechnology; cat. no. S0033S; 1:1,000), AGEs (200 µg/ml) or AGEs (200 µg/ml) + KWG (5, 30 or 70 µM) were administered for 48 h. Levels of ROS (450 nm), SOD (560 nm), GPX (412 nm) and MDA (532 nm) were determined by colorimetric assay on a plate reader according to the protocol from the product supplier.

Determination of ACh, ChAT and AChE

HT22 cells were incubated with vehicle (as a control), AGEs (200 µg/ml) or AGEs (200 µg/ml) + KWG (5 µM) for 12-48 h as indicated; the cell culture supernatant and intracellular fluid (the intracellular fluid was obtained by lysing the cells with RIPA lysis buffer, and then collected the supernatant by centrifugation at 78,400 x g, 4˚C for 10 min) was collected to evaluate levels of Ach (450 nm), ChAT (450 nm) and AChE (450 nm) by colorimetric assay on a plate reader according to the manufacturers' protocol.

Immunofluorescence

Cells were seeded on slides in 6-well cell culture plates (seeding density, 1.2x10⁵ cells/ml) and treated with vehicle (PBS), AGEs (200 µg/ml) or AGEs (200 µg/ml) + KWG (5 µM) at 37˚C for 48 h. After washing with cold PBS, the cells were fixed with 4% paraformaldehyde for 10 min at room temperature and then permeabilized with 0.25% Triton X-100. Rabbit serum (1:20; Gibco; Thermo Fisher Scientific, Inc.) was applied to block unspecific antigens for 30 min at 37˚C. Cells were then incubated with primary antibodies Bcl-2 (1:200), Bax (1:200), IκB-α (1:200) and p-IκB-α (1:200) overnight at 4˚C. After washing with PBS, cells were further incubated with FITC- or Cy3-conjugated secondary antibodies at 4˚C for 12 h. DAPI was applied for nuclear staining. Finally, images were obtained using a confocal laser scanning microscope (Olympus Corporation; magnification, x800).

Western blotting

Total protein from HT22 cells was extracted with RIPA lysis buffer (Santa Cruz Biotechnology, Inc.; cat. no. sc-24948), and the concentration was determined using Bradford assay. Proteins (30 µg/lane) were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis minigel (10%) and then electro-transferred onto PVDF membranes. After blocking with 5% non-fat milk for 12 h at 4˚C, the membranes were incubated with primary antibodies against Bcl-2 (1:1,000), Bax (1:1,000), Akt (1:1,000), p-Akt (1:1,000), p38 MAPK (1:1,000), p-p38 MAPK (1:1,000), NF-κB p65 (1:1,000), p-NF-κB p65 (1:1,000), IκB-α (1:1,000), p-IκB-α (1:1,000), GSK3α/β (1:1,000) or p-GSK3α/β (1:1,000) at 4˚C overnight and then incubated with goat anti-rabbit IgG/FITC (1:6,000) or goat anti-mouse IgG/FITC (1:6,000) horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. The protein bands were visualized using a Bio-Rad Chemi Doc™ XRS system (Bio-Rad Laboratories, Inc.) and band density was measured using ImageJ software (version 1.52; National Institutes of Health). Relative expression of target proteins was calculated based on the value of the internal control GAPDH.

Statistical analysis

Data are expressed as mean ± SD for at least 3 independent experiments. Differences between groups were analyzed by SPSS 22.0 software (IBM Corp.) using one-way ANOVA with a Tukey's post hoc test. P<0.05 was regarded as statistically significant.

Results <sec> <title>KWG alleviates the oxidative stress injury of HT22 cells caused by AGEs

To evaluate the influence of KWG on cell viability was assayed by MTT. AGE administration concentration-dependently induced HT22 cell death (Fig. 1B and C), and co-incubation with 5-70 µM of KWG blocked this trend (Fig. 1D and E); the most significant effect of KWG was observed at 5 µM. However, once the concentration of KWG was higher than 70 µM, an inhibition effect of KWG on cell viability was shown. The above findings were further verified by flow cytometry according to Annexin V-FITC/PI double staining in HT22 cells (Fig. 1J and K). The aim of the present study was to explore effects of KWG on ACh production in HT22 cells. As 400 µg/ml AGEs was found to have significant effects on reducing cell viability and a large number of cells were dead. Converging from reports and previous studies, 200 µg/ml of AGEs were applied in the present study (25).

In the present study, AGE-induced MDA and ROS elevation was observed to be decreased by KWG treatment (Fig. 1F and G). At the same time, AGEs-induced SOD and GPX reduction was reversed by KWG treatment (Fig. 1H and I). At the same time, a high dose of KWG was also found to possess cytotoxic effects on viability of HT22 cells, while 5 µmol/l KWG inhibited effects of 200 µg/ml of AGEs on cell viability. Thus, 5 µM of KWG was used in the present study.

Kuwanon G (KWG) regulated expression of Bcl-2/Bax proteins in AGE-treated cells

Bcl-2 family proteins play a pivotal role in modulating cell viability (26). Western blotting and immunofluorescence were used to evaluate influence of KWG on Bcl-2 family protein expression (Fig. 2A-G). The results indicated that AGE treatment significantly increased expression of pro-apoptotic Bax and decreased anti-apoptotic Bcl-2 expression in comparison with control treatment and that KWG administration was able to alleviate the AGE-induced effects.

Acetylcholine (ACh) production was increased by KWG

Reduction of Ach is believed to be responsible for brain regression disease, including diabetic encephalopathy (27-30). Intracellular and extracellular levels of ACh after AGE administration and KWG treatment were determined by ELISA kits. As indicated in Fig. 3A and B, AGEs significantly reduced ACh content within the cells compared to control and KWG administration could restore the level of ACh both in- and outside of HT22 cells. The expression of AchE and ChAT were assessed and the results showed that AGEs significantly reduced AChE content within the cells, and KWG restored the level of AChE both in- and -outside of HT22 cells (Fig. 3C and D). At the same time, KWG reduced the secretion of ChAT induced by AGEs both in- and -outside of HT22 cells (Fig. 3E and F). This finding suggests that KWG may protect against diabetic encephalopathy via increasing ACh production.

Effects of Kuwanon G on AGEs-induced of PI3K/AKT/GSK3αβ/P38 MAPK/NF-κB p65/Iκb-α signaling pathway in HT22 cells

In order to further explore the underlying mechanism, some intracellular signaling pathway proteins were evaluated by western blotting. As shown in Fig. 4A-K, expression and activation of AKT and IκB-α was restored by KWG administration, while AGE induced phosphorylation of signaling proteins including GSK3α/β, p38 MAPK and NF-κB p65 was reduced by KWG.

Discussion

The diabetic population are at significant risk of developing neurodegenerative disease. Although both peripheral and central nerves can be influenced, greater focus should be on the prevention of diseases causing brain dysfunction, as cognitive and memory impairment will seriously influence patient quality of life (25,31). The accumulation of AGEs has been demonstrated to contribute to diabetic encephalopathy (32). The results of the present study suggested that Kuwanon G (KWG) may be able to inhibit AGE-induced neuron loss and dysfunction and the possible mechanism was also explored.

Diabetic encephalopathy is a condition closely related to both aging and hyperglycemia. Although the underlying pathophysiological mechanism of this condition remains to be elucidated, existing evidence suggests that accumulation of AGEs may be a related factor (33). AGEs refer to a group of stable metabolic products of macromolecules including proteins, amino acids, lipids or nucleic acids in the body that are glycated following exposure to sugars under non-enzymatic conditions (34-36). The two pivotal factors suggested to have a role in AGE production are hyperglycemia and oxidative stress (37,38). In the present study AGEs were applied in order to construct an in vitro diabetic encephalopathy model in HT22 cells (39,40), a mouse hippocampal neuron cell line commonly used to study neurodegenerative disease (41,42). Reports concerning correlation between AGEs and diabetes are abundant and AGEs have been demonstrated to play a role in promoting diabetic neuropathy (32,40,43). However, interventions specifically addressing AGEs remain very limited.

Cortex Mori (CM) is a TCM commonly thought to be beneficial in the treatment of diabetes (44-46). However, its active components are not well understood. KWG is a flavonoid that can be found in CM, but there has been limited study of its pharmacological activity. A recent finding suggested that KWG inhibited α-glucosidase activity (14). This finding was verified by Paudel et al (9) in HepG2 cells where it was additionally shown that as well as inhibiting α-glucosidase, KWG could also inhibit PTP1B, promote binding between insulin and the insulin receptor and alleviate insulin resistance. The above findings suggest the possibility that KWG might be a beneficial therapy for diabetes. Our previous study also demonstrated that KWG had a protective effect against diabetic endotoxemia via reducing inflammatory cytokine expression and alleviating oxidative stress (12). This supplies further evidence that KWG may have anti-inflammatory and anti-aging effects.

In the present study, the aim to was explore the potential therapeutic effect of KWG on diabetic encephalopathy. To first exclude a possibility that KWG may increase viability of HT22 cells, MTT assay was carried out. KWG at 5 µM did not have significant effect on cell viability; but KWG at 5 µM could inhibit effect of AGEs on reducing cell viability as well as ROS production, suggesting that KWG has an effect against AGE-induced cell damage. Further study found that KWG protected HT22 cells against AGE-induced damage via anti-oxidative stress and anti-inflammation related signaling pathways. Although further work remains to be carried out, the present findings support the conclusion that KWG may promote the production and secretion of ACh and protect hippocampal neurons from oxidative toxicity induced by AGEs.

As oxidative stress can facilitate accumulation and function of AGEs and therefore contribute to progression of neuron loss and diabetic encephalopathy (47-49), whether KWG could reduce AGE-induced ROS production was investigated. Additionally, levels of SOD, GPX and MDA were assessed and the results indicated that KWG increased the expression of SOD, GPX and reduced the secretion of MDA following AGE administration. This is in line with findings from both our group (12) and other research groups (50). Another factor that accounts for cell viability loss is apoptosis. By both flow cytometry and immunocytochemistry, it was demonstrated that KWG could inhibit HT22 cell apoptosis induced by AGEs via increasing anti-apoptotic Bcl-2 and decreasing pro-apoptotic Bax expressions. Preservation of cell number may inhibit progression of neurodegenerative disease.

ACh is a major neurotransmitter in the brain and its deficition leads to cognitive dysfunction. Dysfunction in the production and/or secretion of ACh is the basic variation that contributes to memory loss (31,51,52). To evaluate whether KWG could preserve ACh levels in AGE treated HT22 cells, its content was determined by an ELISA kit. AGE administration significantly reduced the level of ACh within the cells, suggesting that accumulation of AGEs within brain tissue may promote neuro-dysfunction. Dementia and diabetes share some pathological process, including neuroinflammation, abnormal AChE levels, insulin resistance and decreased glucose metabolism (53). Studies found that during the course of diabetic encephalopathy, it was usually accompanied by decreased secretion of ACh, and increased production of AChE (28,54). The expression levels of ChAT and AChE were also assessed, and the results suggested that KWG administration could restore the level of ChAT both in- and -outside of HT22 cells following AGE treatment. At the same time, KWG reduced the secretion of AChE induced by AGEs both in- and -outside of cells. It was also observed that KWG increased the production of ChAT while inhibiting the secretion of AChE. This result shows that KWG may be beneficial in preventing the occurrence of diabetic encephalopathy.

Direct correlation between inflammation and cognitive impairment has been demonstrated in numerous studies (55-59). In diabetes, the interaction between AGE and its receptors results in the production of ROS and activation of signaling pathways, including that of p38 MAPK and NF-κB (60). A previous study indicated that increased formation of AGEs also leads to inactivation of PI3K/AKT signaling cascade, which further activates the GSK3 pathway and promotes production of pro-inflammatory cytokines (61). Activation of GSK3 signaling pathways and oxidative stress in the brain may inhibit the expression of Bcl-2(62). In this sense, AGEs, ROS, PI3K/AKT and MAPK activation are linked and are key contributors in the pathogenesis of diabetic cognitive dysfunction. The expression and activation of the above signaling pathway proteins was assessed in the present study. The results suggested that KWG increased the phosphorylation of AKT and IκB-α and decreased the phosphorylation of GSK3α, GSK3β, P38 and MAPK/NF-κB p65. Phosphorylation of IκB-α is generally believed to be related to NF-κB p65 nuclear translocation and inflammatory events (63). In the present study, KWG administration appeared to increase activation of AKT. It has been previously demonstrated that phosphorylation of AKT will contribute to p-IκB-α activation (64). In the present sudy KWG increased both AKT and phosphorylation of IκB-α, this is in line with conventional findings. However, NF-κB p65 activation was inhibited by KWG. This is obviously conflict with that of p-IκB-α. To explain this phenomenon, activation of GSK3, which plays pivotal role in inflammation, was assessed within cells. It has been demonstrated that GSK3 plays key role in modulating NF-κB p65 activation in that p65 is phosphorylated in vitro by this kinase (65), in this sense, GSK3 modulated activation of p65 after IκB. However, the underlying mechanism deserves further investigation.

One consideration is the bioavailability of KWG to neurons, i.e. its permeability across biological barriers including the blood-brain barrier (BBB). Permeability of flavonoids across the BBB is affected by their lipophilicity and interaction with efflux transporters. Studies from Youdim et al (66,67) suggested two flavonoids, naringenin and quercetin, can cross BBB in vivo. Both clinical and experimental studies have also suggested that the integrity of both the gut-barrier and the BBB is damaged and that permeability of these two barriers is increased (12,66-68), suggesting that greater quantities of flavonoids may cross biological barriers under diabetic settings. However, more work should be carried out to further demonstrate this hypothesis.

In conclusion, the present study suggests that KWG can promote both the production and secretion of ACh and can protect hippocampal neurons from oxidative toxicity induced by AGEs. The present findings indicate that KWG may be a potential candidate for the prevention of diabetic neurodegenerative disease.

Acknowledgements

The authors would like to thank Professor Lu Ming from the Department of Pharmacology (Nanjing Medical University, China) for providing the HT22 cell line.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Authors' contributions

WJG, CLG, DKG and YHX designed the experiments. WJG, CLG, WQZ and JLG carried out the western blotting and immunofluorescence experiments. WJG, TTZ, HLG, LLY and LFL carried out ELISA. HZ, YX and YHX analyzed the data. WJG, CLG and YHX drafted the manuscript. HZ, YX and DKG revised the manuscript. All authors read and approved the final manuscript.

Ethical approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

All authors declare that they have no competing interests.

References 1

Markowicz-Piasecka

Sikora

Szydłowska

Skupień

Mikiciuk-Olasik

Huttunen

Metformin - a future therapy for neurodegenerative diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Pharm Res34261426272017

28589443

10.1007/s11095-017-2199-y

Gireesh

Kumar

Mathew

Paulose

Enhanced muscarinic M1 receptor gene expression in the corpus striatum of streptozotocin-induced diabetic rats

J Biomed Sci16382009

19344500

10.1186/1423-0127-16-38

Saliu

Oboh

Omojokun

Rocha

JBT

Schetinger

Guterries

Stefanello

Carvalho

Schmatz

Morsch

Effect of dietary supplementation of Padauk (Pterocarpus soyauxii) leaf on high fat diet/streptozotocin induced diabetes in rats’ brain and platelets

Biomed Pharmacother84119412012016

27788477

10.1016/j.biopha.2016.10.043

Zhao

Liu

Zhang

Guo

Chen

Zhao

Neuroprotective effects of an Nrf2 agonist on high glucose-induced damage in HT22 cells

Biol Res52532019

31542051

10.1186/s40659-019-0258-z

Waslo

Bourdette

Gray

Wright

Spain

Lipoic acid and other antioxidants as therapies for multiple sclerosis

Curr Treat Options Neurol21262019

31056714

10.1007/s11940-019-0566-1

Eckert

Eckmann

Hagl

Muller

Friedland

Olesoxime improves cerebral mitochondrial dysfunction and enhances Aβ levels in preclinical models of Alzheimer's disease

Exp Neurol3291132862020

32199815

10.1016/j.expneurol.2020.113286

Balamurugan

Santharaman

Madasamy

Rajesh

Sethy

Bhargava

Kotamraju

Karunakaran

Recent trends in electrochemical biosensors of superoxide dismutases

Biosens Bioelectron11689992018

29860091

10.1016/j.bios.2018.05.040

Jiao

Wang

Guo

Wang

Glutathione peroxidases as oncotargets

Oncotarget880093801022017

29108391

10.18632/oncotarget.20278

Paudel

Seong

Kuk

Jung

Choi

Protein tyrosine phosphatase 1B inhibition and glucose uptake potentials of mulberrofuran G, Albanol B, and Kuwanon G from root bark of Morus alba L. in insulin-resistant HepG2 cells: An in vitro and in silico study

Int J Mol Sci19E15422018

29786669

10.3390/ijms19051542

Nourazarian

Kangari

Salmaninejad

Roles of oxidative stress in the development and progression of breast cancer

Asian Pac J Cancer Prev15474547512014

24998536

10.7314/apjcp.2014.15.12.4745

Lee

Park

Kim

Kwon

Jang

Han

Morita

Her

Antidepressant-like effects of Cortex Mori Radicis extract via bidirectional phosphorylation of glucocorticoid receptors in the hippocampus

Behav Brain Res23656612013

22940457

10.1016/j.bbr.2012.08.028

Guo

Huang

Zhou

Zheng

Zhao

Zhu

Tang

Zhu

Kuwanon G preserves LPS-induced disruption of gut epithelial barrier in vitro

Molecules21E15972016

27879681

10.3390/molecules21111597

You

Kim

Protective effect of Mori Cortex radicis extract against high glucose-induced oxidative stress in PC12 cells

Biosci Biotechnol Biochem83189319002019

31130105

10.1080/09168451.2019.1621154

Chen

Yang

Cui

Zhang

Comparative study of chemical composition and active components against α-glucosidase of various medicinal parts of Morus alba L

Biomed Chromatogr32e43282018

29975423

10.1002/bmc.4328

Wei

Chen

Pais

EMA

Wang

Miao

Qiu

Gao

Oxyresveratrol is a phytoestrogen exerting anti-inflammatory effects through NF-κB and estrogen receptor signaling

Inflammation40128512962017

28484893

10.1007/s10753-017-0572-y

Lee

Lyu

Koo

Nam

Hong

Kim

Lee

Mar

Protection of prenylated flavonoids from Mori Cortex Radicis (Moraceae) against nitric oxide-induced cell death in neuroblastoma SH-SY5Y cells

Arch Pharm Res351631702012

22297755

10.1007/s12272-012-0118-7

Yuan

Zhao

Zhou

Jehangir

Wang

Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats

Chin J Nat Med164114172018

30047462

10.1016/S1875-5364(18)30074-8

Liu

Zhang

Wang

Cao

Sun

Kuwanon G attenuates atherosclerosis by upregulation of LXRα-ABCA1/ABCG1 and inhibition of NFκB activity in macrophages

Toxicol Appl Pharmacol34156632018

29355567

10.1016/j.taap.2018.01.007

Kuk

Sohn

Seong

Roy

Choi

Jung

Anti-Alzheimer's disease activity of compounds from the root bark of Morus alba L

Arch Pharm Res403383492017

28093699

10.1007/s12272-017-0891-4

Gong

Zhang

Liu

Zhu

Zhang

Wang

Regulatory function of Pja2 mediated by the P2rx3/P2rx7 axis in mouse hippocampal neuronal cells

Am J Physiol Cell Physiol318C1123C11352020

32267716

10.1152/ajpcell.00070.2019

Cancela

Canclini

Mourglia-Ettlin

Hernández

Merlino

Neuroprotective effects of novel nitrones: In vitro and in silico studies

Eur J Pharmacol8711729262020

31958456

10.1016/j.ejphar.2020.172926

Wang

Feng

Zhu

Xiang

Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation

Int Immunopharmacol10155215592010

20875828

10.1016/j.intimp.2010.09.006

Feng

Wang

Zhu

Lin

Lou

Xiang

Zheng

Tang

Phytoestrogen calycosin-7-O-β-D-glucopyranoside ameliorates advanced glycation end products-induced HUVEC damage

J Cell Biochem112295329652011

21647942

10.1002/jcb.23212

Feng

Wang

Zhu

Zheng

Xiang

Tang

Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration

J Ethnopharmacol1373593702011

21669275

10.1016/j.jep.2011.05.041

Leng

Tian

Liu

Guo

Zhang

Chu

Wang

Zhang

Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the Nrf2/HO-1 pathway

BMC Complement Med Ther201262020

32336289

10.1186/s12906-020-02930-7

Voehringer

BCL-2 and glutathione: Alterations in cellular redox state that regulate apoptosis sensitivity

Free Radic Biol Med279459501999

10569627

10.1016/s0891-5849(99)00174-4

Scremin

Roch

Norman

Djazayeri

Liu

Brain acetylcholine and choline concentrations and dynamics in a murine model of the Fragile X syndrome: Age, sex and region-specific changes

Neuroscience3015205282015

26117713

10.1016/j.neuroscience.2015.06.036

Zhou

Zhu

Han

Chen

Liu

Fan

Yin

Quantitative-profiling of neurotransmitter abnormalities in the disease progression of experimental diabetic encephalopathy rat

Can J Physiol Pharmacol93100710132015

26426748

10.1139/cjpp-2015-0118

Liapi

Kyriakaki

Zarros

Galanopoulou

Al-Humadi

Dontas

Voumvourakis

Tsakiris

Choline-deprivation alters crucial brain enzyme activities in a rat model of diabetic encephalopathy

Metab Brain Dis252692762010

20838865

10.1007/s11011-010-9205-y

Aykac

Ozbeyli

Uncu

Ertaş

Kılınc

Şen

Orun

Sener

Evaluation of the protective effect of Myrtus communis in scopolamine-induced Alzheimer model through cholinergic receptors

Gene6891942012019

30553998

10.1016/j.gene.2018.12.007

Argente-Pla

Pérez-Lázaro

Martinez-Millana

Del Olmo-García

Espí-Reig

Beneyto-Castello

López-Andújar

Merino-Torres

Simultaneous pancreas kidney transplantation improves cardiovascular autonomic neuropathy with improved valsalva ratio as the most precocious test

J Diabetes Res202075746282020

32337297

10.1155/2020/7574628

Zhu

Cheng

Yin

Liu

Enhancement of glyoxalase 1, a polyfunctional defense enzyme, by quercetin in the brain in streptozotocin-induced diabetic rats

Naunyn Schmiedebergs Arch Pharmacol391123712452018

30062553

10.1007/s00210-018-1543-z

Zhang

Feng

Cui

Gao

Protective effects of grape seed proanthocyanidin extracts on cerebral cortex of streptozotocin-induced diabetic rats through modulating AGEs/RAGE/NF-kappaB pathway

J Nutr Sci Vitaminol (Tokyo)5687972010

20495289

10.3177/jnsv.56.87

Luévano-Contreras

Gómez-Ojeda

Macías-Cervantes

Garay-Sevilla

Dietary advanced glycation end products and cardiometabolic risk

Curr Diab Rep17632017

28695383

10.1007/s11892-017-0891-2

Singh

Barden

Mori

Beilin

Advanced glycation end-products: A review

Diabetologia441291462001

11270668

10.1007/s001250051591

Gurav

Advanced glycation end products: A link between periodontitis and diabetes mellitus?

Curr Diabetes Rev93553612013

23845077

10.2174/15733998113099990066

Shumilina

Kusnetsova

Tsarev

Janse van Rensburg

Medvedev

Demidchik

Van den Ende

Frolov

Glycation of plant proteins: Regulatory roles and interplay with sugar signalling?

Int J Mol Sci2023662019

31086058

10.3390/ijms20092366

Bellier

Nokin

Lardé

Karoyan

Peulen

Castronovo

Bellahcène

Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer

Diabetes Res Clin Pract1482002112019

30664892

10.1016/j.diabres.2019.01.002

Dafre

Schmitz

Maher

Methylglyoxal-induced AMPK activation leads to autophagic degradation of thioredoxin 1 and glyoxalase 2 in HT22 nerve cells

Free Radic Biol Med1082702792017

28363601

10.1016/j.freeradbiomed.2017.03.028

Sung

Woo

Kim

Son

Lee

Song

Sildenafil ameliorates advanced glycation end products-induced mitochondrial dysfunction in HT-22 hippocampal neuronal cells

J Korean Neurosurg Soc592592682016

27226858

10.3340/jkns.2016.59.3.259

Chen

Zhang

Guan

Wang

Anti-oxidative stress activity is essential for Amanita caesarea mediated neuroprotection on glutamate-induced apoptotic HT22 cells and an Alzheimer's disease mouse model

Int J Mol Sci18E16232017

28749416

10.3390/ijms18081623

Liu

Suo

HT22 hippocampal neuronal cell line possesses functional cholinergic properties

Life Sci842672712009

19135458

10.1016/j.lfs.2008.12.008

Singh

Bali

Singh

Jaggi

Advanced glycation end products and diabetic complications

Korean J Physiol Pharmacol181142014

24634591

10.4196/kjpp.2014.18.1.1

Chen

Nakashima

Kimura

Hypoglycemic activity and mechanisms of extracts from mulberry leaves (folium mori) and cortex mori radicis in streptozotocin-induced diabetic mice

Yakugaku Zasshi1154764821995

7666358

10.1248/yakushi1947.115.6_476

(In Japanese)

Lemus

García

Delvillar

Knop

Hypoglycaemic activity of four plants used in Chilean popular medicine

Phytother Res1391941999

10190178

10.1002/(SICI)1099-1573(199903)13:2<91::AID-PTR350>3.0.CO;2-8

Cai

Sun

Fan

Guo

Hou

Zhao

Feng

Liu

Effect of mulberry leaf (Folium Mori) on insulin resistance via IRS-1/PI3K/Glut-4 signalling pathway in type 2 diabetes mellitus rats

Pharm Biol54268526912016

27158744

10.1080/13880209.2016.1178779

Samarghandian

Azimi-Nezhad

Samini

Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus

BioMed Res Int20149208572014

25114929

10.1155/2014/920857

Jiang

Wang

Huang

Yang

Cai

Role of the glyoxalase system in Alzheimer's disease

J Alzheimers Dis668878992018

30400091

10.3233/JAD-180413

Joubert

Manrique

Cariou

Prieur

Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathways

Diabetes Metab452382472019

30078623

10.1016/j.diabet.2018.07.003

Abbas

Abdel Bar

Baraka

Gohar

Lahloub

A new antioxidant stilbene and other constituents from the stem bark of Morus nigra L

Nat Prod Res289529592014

24673367

10.1080/14786419.2014.900770

Tzavara

Bymaster

Overshiner

Davis

Perry

Wolff

McKinzie

Witkin

Nomikos

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine

Mol Psychiatry111871952006

16231039

10.1038/sj.mp.4001763

Kumamoto

Kuba

Sustained rise in ACh sensitivity of a sympathetic ganglion cell induced by postsynaptic electrical activities

Nature3051451461983

6604228

10.1038/305145a0

Agatonovic-Kustrin

Kustrin

Morton

Essential oils and functional herbs for healthy aging

Neural Regen Res144414452019

30539810

10.4103/1673-5374.245467

Pandey

Garabadu

Piracetam facilitates the anti-amnesic but not anti-diabetic activity of metformin in experimentally induced type-2 diabetic encephalopathic rats

Cell Mol Neurobiol377918022017

27585927

10.1007/s10571-016-0418-4

Song

Chung

Kim

Maeng

Relationship between the hs-CRP as non-specific biomarker and Alzheimer's disease according to aging process

Int J Med Sci126136172015

26283879

10.7150/ijms.12742

Gregor

Hotamisligil

Inflammatory mechanisms in obesity

Annu Rev Immunol294154452011

21219177

10.1146/annurev-immunol-031210-101322

Gorska-Ciebiada

Saryusz-Wolska

Borkowska

Ciebiada

Loba

Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment

PLoS One10e01204332015

25793613

10.1371/journal.pone.0120433

John

Mohamed Yusof

NIS

Abdul Aziz

Mohd Fauzi

Maternal cognitive impairment associated with gestational diabetes mellitus: A review of potential contributing mechanisms

Int J Mol Sci19E38942018

30563117

10.3390/ijms19123894

Meng

Wang

Kang

Wang

Sun

Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats

Exp Ther Med13241724222017

28565857

10.3892/etm.2017.4259

Parveen

Kim

Subedi

Khan

Kim

Phytochemicals: Target-based therapeutic strategies for diabetic retinopathy

Molecules23E15192018

29937497

10.3390/molecules23071519

Liang

Zhang

Kang

Meng

Yang

Xue

Gao

Han

Gou

Protective effects of rutin on liver injury in type 2 diabetic db/db mice

Biomed Pharmacother1077217282018

30138894

10.1016/j.biopha.2018.08.046

Butterfield

Di Domenico

Barone

Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain

Biochim Biophys Acta1842169317062014

24949886

10.1016/j.bbadis.2014.06.010

Han

Gao

Chen

Wang

Luo

Zhao

Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells

Sci Rep9150872019

31636354

10.1038/s41598-019-51614-x

Botchway

BOA

Zhang

Zhou

Liu

Inhibition of NF-κB signaling pathway by resveratrol improves spinal cord injury

Front Neurosci126902018

30337851

10.3389/fnins.2018.00690

Ghosh

Hayden

New regulators of NF-kappaB in inflammation

Nat Rev Immunol88378482008

18927578

10.1038/nri2423

Youdim

Qaiser

Begley

Rice-Evans

Abbott

Flavonoid permeability across an in situ model of the blood-brain barrier

Free Radic Biol Med365926042004

14980703

10.1016/j.freeradbiomed.2003.11.023

Youdim

Dobbie

Kuhnle

Proteggente

Abbott

Rice-Evans

Interaction between flavonoids and the blood-brain barrier: In vitro studies

J Neurochem851801922003

12641740

10.1046/j.1471-4159.2003.01652.x

Bogush

Heldt

Persidsky

Blood brain barrier injury in diabetes: Unrecognized effects on brain and cognition

J Neuroimmune Pharmacol125936012017

28555373

10.1007/s11481-017-9752-7

Figure 1

Effect of KWG on the viability and AGE induced-oxidative stress of HT22 cells. (A) Chemical structure of KWG. (B) Cell viability was determined by MTT after (B) 24-h and (C) 48-h AGE treatment, (D) 48-h KWG treatment and (E) after a combined treatment with AGE and KWG for Xh. (F) Levels of ROS, (G) MDA, (H) SOD and (I) GPX were assayed. (J) HT22 cell apoptosis levels were determined by flow cytometry and (K) quantified. ^*P<0.05, ^**P<0.01. AGE, advanced glycation end products; BSA, bovine serum albumin; GPX, glutathione peroxidase; KWG, kuwanon G; MDA, malondialdehyde; NC, normal control; ROS, reactive oxygen species ; SOD, superoxide dismutase.

Figure 2

Expression of Bcl-2 and Bax protein was determined by immunofluorescence (magnification, x800) and western blotting. (A) Bcl-2 and (B) Bax proteins were stained using IF. (C) Bcl-2 IF quantification. (D) Bax IF quantification. (E) Bcl-2 and (F) Bax protein levels were also quantified using (G) western blot analysis. ^**P<0.01. AGE, advanced glycation end products; IF, immunofluorescence; KWG, kuwanon G; WB, western blotting.

Figure 3

KWG increases ACh and ChAT production and decreases AchE secretion induced by AGEs. Intracellular levels of (A) ACh, (B) AchE and (C) ChAT after AGEs or AGE + KWG treatment were detected by an ELISA kit. Extracellular levels of (D) ACh, (E) AchE and (F) ChAT were also determined after AGEs or AGE + KWG treatment ^*P<0.05, ^**P<0.01. ACh, acetylcholine; AChE, acetylcholinesterase; AGE, advanced glycation end products; ChAT, choline acetyltransferase; KWG, kuwanon G; NC, normal control

Figure 4

KWG modulates AGEs-induced signaling pathways in HT22 cells. (A) Iκb-α and (B) p-Iκb-α were detected by immunofluorescence (magnification, x800) and (C) their levels quantified. Levels of total and p-(D) Akt, (E) p38-MAPK and (F) NF-κB p65 were assessed by western blot. Levels of quantification of (F) AKT, (G) MAPK and (H) NF-κB p65 are shown. (I) GSK3α and β levels were also determined by western blot. Quantification of (J) GSK3β and (K) GSK3α is shown in a graph. ^*P<0.05, ^**P<0.01. AGE, advanced glycation end products; KWG, kuwanon G.